rolofylline has been researched along with Kidney Failure, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cleland, JG; Cotter, G; Davison, BA; Dittrich, HC; Givertz, MM; Hillege, HL; Mansoor, GA; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Postmus, D; Teerlink, JR; Voors, AA | 1 |
| Dohadwala, MM; Givertz, MM | 1 |
| Bird, S; Cotter, G; Dittrich, H; Gergich, K; Givertz, MM; Gottlieb, SS; Jones-Burton, C; Massie, B; Metra, M; O'Connor, C; Ponikowski, P; Weatherley, B | 1 |
1 review(s) available for rolofylline and Kidney Failure, Chronic
| Article | Year |
|---|---|
Role of adenosine antagonism in the cardiorenal syndrome.
Topics: Adenosine A1 Receptor Antagonists; Animals; Heart Failure; Hospital Mortality; Humans; Kidney Failure, Chronic; Registries; Syndrome; Xanthines | 2008 |
2 other study(ies) available for rolofylline and Kidney Failure, Chronic
| Article | Year |
|---|---|
Renal function trajectories and clinical outcomes in acute heart failure.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Urea Nitrogen; Comorbidity; Creatinine; Female; Follow-Up Studies; Heart Failure; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Models, Biological; Multivariate Analysis; Predictive Value of Tests; Purinergic P1 Receptor Antagonists; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Xanthines | 2014 |
The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study.
Topics: Adenosine A1 Receptor Antagonists; Aged; Confidence Intervals; Creatinine; Diuretics; Female; Humans; Kidney Failure, Chronic; Male; Odds Ratio; Pilot Projects; Prognosis; Receptor, Adenosine A1; Renal Dialysis; Risk Assessment; Treatment Outcome; United States; Xanthines | 2010 |